UNSPSC 51191580: Prorenoate potassium

This classification denotes a potassium-sparing diuretic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T2D4XUS623. European Medicines Agency schedules Prorenoate potassium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10129MIG.

Prorenoate potassium generally arises in the molecular formula C23H31O4.K. The term PRORENOATE POTASSIUM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 29, no. 10 1975, list 15.) Most nations, for tariff and trade purposes, schedule prorenoate potassium under HS 29372900 and SITC 54153. As of Q4 2014, PRORENOATE POTASSIUM remains US FDA's Preferred Term for this commodity. Prorenoate potassium bears US NLM identifiers UMLS ID C0072213 and NCI Concept Code C84118.

UNSPSC 51191580 Prorenoate potassium is a Commodity code that in practice captures specialized chemical and pharmaceutical products supplied to state and local government operations. Recent state and local solicitations under this code show no actual procurement of prorenoate potassium itself; instead, issuing bodies are buying related but distinct commodities — parenteral pharmaceutical products and services (intravenous solutions, nutrition preparations, and controlled substances), industrial water-treatment chemicals (sodium bisulfite), and specialized valve components with integrated control systems for wastewater facilities. The mix of issuing bodies includes state corrections departments, municipal water and wastewater utilities, and county public-health infrastructure operators. Work solicited ranges from multi-facility medical supply contracts with strict delivery-time requirements and quality-assurance protocols to single-facility industrial chemical supply with performance and payment-bond requirements.

Geographic activity appears concentrated in the Pacific Northwest and Mid-Atlantic regions. The Washington State Department of Corrections is procuring parenteral products and services for eight correctional facilities statewide under an RFQ (RFQQK13020) with responses due October 7, 2026, targeting fixed pricing through June 30, 2030, with opportunities for multiple award across three regional zones and set-aside targets for small, minority-owned, women-owned, and veteran-owned businesses totaling 46%. The City of Meriden, Connecticut issued an IFB (B027-15) for sodium bisulfite chemical supply to its Water Pollution Control Facility. Broward County, Florida posted an RFI (BLD6232026F23) on September 18, 2026 regarding DeZurik/APCO valves, parts, and repair services for wastewater compliance, with response due September 29, 2026, to evaluate whether alternatives exist to the current exclusive provider. The code shows little direct procurement of prorenoate potassium by state and local authorities, suggesting either low demand for the commodity itself or potential misclassification of recent opportunities within this Commodity tier.